Accelerate: Accelerate Diagnostics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024

Accelerate Diagnostics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was USD 2.98 million compared to USD 3.3 million a year ago. Net loss was USD 14.64 million compared to net income of USD 0.91 million a year ago. Basic loss per share from continuing operations was USD 0.59 compared to basic earnings per share from continuing operations of USD 0.06 a year ago. For the nine months, sales was USD 8.88 million compared to USD 9.03 million a year ago. Net loss was USD 40.46 million compared to USD 48.62 million a year ago. Basic loss per share from continuing operations was USD 1.78 compared to USD 4.13 a year ago.